June 2026
The global neurological rare disease biologics market is growing as advanced biologics address unmet needs in rare neurological disorders.
June 2026
The rare diseases treatment market size was estimated at USD 244.57 billion in 2025 and is predicted to hit around USD 566.83 billion by 2035 with a CAGR of 8.77%.
September 2025
The rare disease small-batch CDMO market is expanding with demand for specialized manufacturing of orphan drugs and niche therapies.
July 2025
The biological safety testing market size was evaluated at USD 4.85 billion in 2024 and is predicted to surpass around USD 17.00 billion by 2034, with a CAGR of 13.36%.
July 2025
Explore the single dose gene therapy market as one-time treatments redefine the future of genetic disorder management and patient care.
June 2025
The global plasma protein therapeutics market size is projcetd to cross around USD 48.43 billion by 2034 from USD 29.56 billion in 2024 with a CAGR of 5.06%.
June 2026
The global chronic disease management market size was estimated at USD 6.61 billion in 2025 and is expected to hit around USD 23.18 billion by 2035, growing at a CAGR of 13.37% from 2026 to 2035.
June 2026
The RNA editing for neurodegenerative diseases market is growing as advanced RNA technologies target conditions like Alzheimer’s and Parkinson’s.
June 2026
The rare musculoskeletal disorder treatments market is growing as innovation targets therapies for underserved and complex conditions.
June 2026
The global remote neurological monitoring market size was evaluated at USD 2.45 billion in 2025 and is predicted to hit around USD 9.69 billion by 2035, growing at a CAGR of 14.80%.
June 2026
The US biologics market size was evaluated at USD 203.60 billion in 2025 and is predicted to hit around USD 525.67 billion by 2035, growing at a CAGR of 9.95 %.
June 2026
The global stem cell therapy for neurological disorders market size was evaluated at USD 2.38 billion in 2025 and is predicted to hit around USD 12.67 billion by 2035, growing at a CAGR of 17.90%.
June 2026
The global Huntingtons disease market size was evaluated at USD 1.42 billion in 2025 and is predicted to hit around USD 6.48 billion by 2035, growing at a CAGR of 17.20%.
June 2026
The global autoimmune neurological disorders market size was evaluated at USD 8.50 billion in 2025 and is predicted to hit around USD 17.79 billion by 2035, growing at a CAGR of 7.90%.
June 2026
The global sickle cell disease treatment market size is predicted to hit around USD 15.81 billion by 2035 from USD 3.75 billion in 2025 with a CAGR of 15.48%.
May 2026
The infectious respiratory disease diagnostics market size is projected to hit around USD 96.57 billion by 2035 from USD 57.55 billion in 2025 with a CAGR of 5.31%.
May 2026
The global disease management apps market size is calculated at USD 10.20 billion in 2025 and is projected to hit around USD 27 billion by 2035 with a CAGR of 10.22%.
May 2026
The global diabetic kidney disease market size was valued at USD 3.25 billion in 2025 and is projected to hit around USD 5.23 billion by 2035 with a CAGR of 4.87%.
May 2026
The neurological biomarkers market size reached USD 10.32 billion in 2025 and is projected to surpass around 34.02 billion by 2035, with a solid CAGR of 12.67%.
May 2026
The global graves disease (overactive thyroid) market size is estimated to hit around USD 3.69 billion by 2035 increasing from USD 2.26 billion in 2025, with a CAGR of 5.02%.
May 2026
The global Alzheimers disease diagnostics market size was evaluated at USD 9.40 billion in 2025 and is predicted to hit around USD 26.21 billion by 2035, growing at a CAGR of 10.80%.
May 2026
The global Parkinsons disease biomarkers market size was evaluated at USD 1.35 billion in 2025 and is predicted to hit around USD 4.88 billion by 2035, growing at a CAGR of 13.80%.
April 2026
The global inflammatory bowel disease treatment market size is projected to hit around USD 32.46 billion by 2035 from USD 22.38 billion in 2025, with a CAGR of 3.79%.
April 2026
The global inflammatory disease market size was evaluated at USD 125.00 billion in 2025 and is predicted to hit around USD 241.34 billion by 2035, growing at a CAGR of 6.80%.
April 2026
The global enteric disease testing market size was evaluated at USD 4.30 billion in 2025 and is predicted to hit around USD 8.09 billion by 2035, growing at a CAGR of 6.52%.
March 2026
The global cancer biologics market size was valued at USD 117.45 billion in 2025 and is expected to hit around USD 235.81 billion by 2035 with a CAGR of 7.22%.
March 2026
The global periodontal disease treatment market size was evaluated at USD 2.94 billion in 2025 and is predicted to hit around USD 6.23 billion by 2035, growing at a CAGR of 7.80%.
March 2026
Explore key trends and forecasts shaping the rare earth minerals market, including demand drivers, challenges, and future opportunities worldwide.
March 2026
The global infectious disease immunoassay market size was evaluated at USD 2.88 billion in 2025 and is predicted to hit around USD 8.87 billion by 2035, growing at a CAGR of 11.90%.
March 2026
The orthobiologics market size was estimated at USD 7.37 billion in 2025 and is expected to surge around USD 12.55 billion by 2035, with a notable CAGR of 5.47%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com